Modular Medical

MODD · NASDAQ

$1.95−$0.12 (−5.80%)TodayMarket closed ·
Prev close $2.07

About MODD

Modular Medical, Inc. is a development stage company, which engages in the provision of insulin pump technology. The company is headquartered in San Diego, California and currently employs 54 full-time employees. The company went IPO on 2006-01-13. The firm is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The firm's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include two parts - one reusable, one disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; disposable portion removable at any time from an adhesive-backed retainer, which remains in place, and no external controller required, no charging and no battery replacement. MODD1 comes with a variety of methods for the patient to wear the pump. Options include a baseplate with adhesive for attaching to the body that has features for holding the pump to the patient, and overwraps to hold the product to the patient.

Employees
54
Headquarters
San Diego, California
Listed
Jan 13, 2006
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Modular Medical executives
NameTitleSince
Paul Diperna—2017
James Besser—2017
Kevin Schmid——
Morgan Frank—2017
Jeffrey Goldberg——
Ellen Vos—2021
Duane Desisto——
Steven Felsher——
Philip Sheibley——
Carmen Volkart——

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Modular Medical suppliers and customers
CompanyRelationshipCorrelation
CSN Mineracao CMIN3Customer—

Similar companies

Companies in the same industry as Modular Medical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.